In a research enrolling 414 breast cancer patients, the relationship between KATNB1 and the clinicopathological features of breast cancer was studied, and the results indicated that the increased expression of KATNB1 was linked to a higher ratio of patients in the N and TNM stages, indicating that the aberrant expression of KATNB1 in breast cancer patients may promote cancer cell metastasis and migration [30–32]. Here, KATNB1 is linked to breast cancer.